Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Highlights Among Hedge Funds’ Latest Moves

Page 1 of 2

At Insider Monkey we don’t only analyze the quarterly 13F filings of over 730 smart money investors, but we also track their day-to-day moves disclosed via other filings with the SEC. Among the latest hedge fund moves, Jeff Ubben‘s ValueAct Capital reported trimming its stake in Msci Inc (NYSE:MSCI), while James H. Litinsky‘s JHL Capital Group disclosed an increased stake in Unisys Corporation (NYSE:UIS). In another filing, billionaire activist Carl Icahn reported further increasing its stake in Cheniere Energy, Inc. (NYSEMKT:LNG). Let’s take a closer look at these three moves.


Why are we at all interested in the moves of a select group of investors? The reason is simple, through extensive research, we determined that imitating their activity can help retail investors outperform the market. Our strategy focuses on the 15 most popular small-cap picks among the funds we track and it has returned 102% since August 2012, compared to 49% for the S&P 500 ETF (SPY) (read more details here).

Activist fund ValueAct has been a long-term shareholder of Msci Inc (NYSE:MSCI) and in a recent 13F filing it disclosed selling some 1.83 million shares of the company, lowering its stake to 7.48 million shares. The shares have been sold in three transactions at an average price of $67.52 per unit and have lowered ValueAct’s stake in MSCI to 7.3% of the outstanding stock. According to its 13D filing, ValueAct reduced the stake as part of its “ongoing process of portfolio management”. The fund has a representative on Msci Inc (NYSE:MSCI)’s board of directors, D. Robert Hale, who will keep his position and plans to run for reelection at the company’s 2016 annual meeting of shareholders. MSCI’s stock has gained over 12% since the beginning of October and is up by over 38% year-to-date. Msci Inc (NYSE:MSCI) is not very popular among the funds we track, although during the second quarter, the number of funds bullish on the stock went up by eight to 24. Moreover, these investors amassed over 17% of the company’s outstanding stock at the end of June.

Follow Msci Inc.
Trade (MSCI) Now!

Let’s move on to Unisys Corporation (NYSE:UIS) and Cheniere Energy, Inc. (NYSEMKT:LNG), and take a look at JHL Capital and Carl Icahn’s latest move involving their stakes in the company.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!